Literature DB >> 25855626

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Jennifer Ose1, Helena Schock1, Anne Tjønneland2, Louise Hansen2, Kim Overvad3, Laure Dossus4, Françoise Clavel-Chapelon4, Laura Baglietto5, Heiner Boeing6, Antonia Trichopolou7, Vassiliki Benetou8, Pagona Lagiou9, Giovanna Masala10, Giovanna Tagliabue11, Rosario Tumino12, Carlotta Sacerdote13, Amalia Mattiello14, H B As Bueno-de-Mesquita15, Petra H M Peeters16, N Charlotte Onland-Moret17, Elisabete Weiderpass18, Inger T Gram19, Soledad Sánchez20, Mireia Obon-Santacana21, Maria-José Sànchez-Pérez22, Nerea Larrañaga23, José María Huerta Castaño24, Eva Ardanaz25, Jenny Brändstedt26, Eva Lundin27, Annika Idahl28, Ruth C Travis29, Kay-Tee Khaw30, Sabina Rinaldi31, Isabelle Romieu31, Melissa A Merritt32, Marc J Gunter32, Elio Riboli32, Rudolf Kaaks1, Renée T Fortner33.   

Abstract

BACKGROUND: Evidence suggests an etiologic role for inflammation in ovarian carcinogenesis and heterogeneity between tumor subtypes and anthropometric indices. Prospective studies on circulating inflammatory markers and epithelial invasive ovarian cancer (EOC) have predominantly investigated overall risk; data characterizing risk by tumor characteristics (histology, grade, stage, dualistic model of ovarian carcinogenesis) and anthropometric indices are sparse.
METHODS: We conducted a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort to evaluate C-reactive protein (CRP), IL6, and EOC risk by tumor characteristics. A total of 754 eligible EOC cases were identified; two controls (n = 1,497) were matched per case. We used multivariable conditional logistic regression to assess associations.
RESULTS: CRP and IL6 were not associated with overall EOC risk. However, consistent with prior research, CRP >10 versus CRP ≤1 mg/L was associated with higher overall EOC risk [OR, 1.67 (1.03-2.70)]. We did not observe significant associations or heterogeneity in analyses by tumor characteristics. In analyses stratified by waist circumference, inflammatory markers were associated with higher risk among women with higher waist circumference; no association was observed for women with normal waist circumference [e.g., IL6: waist ≤80: ORlog2, 0.97 (0.81-1.16); waist >88: ORlog2, 1.78 (1.28-2.48), Pheterogeneity ≤ 0.01].
CONCLUSIONS: Our data suggest that high CRP is associated with increased risk of overall EOC, and that IL6 and CRP may be associated with EOC risk among women with higher adiposity. IMPACT: Our data add to global evidence that ovarian carcinogenesis may be promoted by an inflammatory milieu. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855626      PMCID: PMC4454588          DOI: 10.1158/1055-9965.EPI-14-1279-T

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

1.  Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort.

Authors:  Alison J Canchola; Ellen T Chang; Leslie Bernstein; Joan A Largent; Peggy Reynolds; Dennis Deapen; Katherine D Henderson; Giske Ursin; Pamela L Horn-Ross
Journal:  Cancer Causes Control       Date:  2010-10-06       Impact factor: 2.506

2.  C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study.

Authors:  Laure Dossus; Aida Jimenez-Corona; Isabelle Romieu; Marie-Christine Boutron-Ruault; Anne Boutten; Thierry Dupré; Guy Fagherazzi; Francoise Clavel-Chapelon; Sylvie Mesrine
Journal:  Cancer Causes Control       Date:  2014-02-07       Impact factor: 2.506

3.  Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer.

Authors:  Louise R Howe; Kotha Subbaramaiah; Clifford A Hudis; Andrew J Dannenberg
Journal:  Clin Cancer Res       Date:  2013-08-19       Impact factor: 12.531

Review 4.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2011-07       Impact factor: 3.466

5.  C-reactive protein concentrations and subsequent ovarian cancer risk.

Authors:  Meghan A McSorley; Anthony J Alberg; Diane S Allen; Naomi E Allen; Louise A Brinton; Joanne F Dorgan; Michael Pollak; Yuzhen Tao; Kathy J Helzlsouer
Journal:  Obstet Gynecol       Date:  2007-04       Impact factor: 7.661

6.  Clinicopathologic and immunohistochemical features of ovarian clear cell carcinomas in comparison with type I and type II tumors.

Authors:  Gian Franco Zannoni; Francesca Morassi; Maria Grazia Prisco; Ilaria De Stefano; Valerio Gaetano Vellone; Vincenzo Arena; Giovanni Scambia; Daniela Gallo
Journal:  Int J Gynecol Pathol       Date:  2012-11       Impact factor: 2.762

7.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

Review 8.  Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  John A Barry; Mallika M Azizia; Paul J Hardiman
Journal:  Hum Reprod Update       Date:  2014-03-30       Impact factor: 15.610

9.  The role of chronic inflammation in obesity-associated cancers.

Authors:  Maria E Ramos-Nino
Journal:  ISRN Oncol       Date:  2013-05-30

10.  Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.

Authors:  H S Kim; T H Kim; H H Chung; Y S Song
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

View more
  22 in total

1.  High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.

Authors:  Lauren C Peres; Adrianne R Mallen; Mary K Townsend; Elizabeth M Poole; Britton Trabert; Naomi E Allen; Alan A Arslan; Laure Dossus; Renée T Fortner; Inger T Gram; Patricia Hartge; Annika Idahl; Rudolf Kaaks; Marina Kvaskoff; Anthony M Magliocco; Melissa A Merritt; J Ramón Quirós; Anne Tjonneland; Antonia Trichopoulou; Rosario Tumino; Carla H van Gils; Kala Visvanathan; Nicolas Wentzensen; Anne Zeleniuch-Jacquotte; Shelley S Tworoger
Journal:  Cancer Res       Date:  2019-08-28       Impact factor: 12.701

2.  Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation.

Authors:  Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2020-07-01       Impact factor: 4.897

3.  Dietary inflammatory index and ovarian cancer risk in a New Jersey case-control study.

Authors:  Nitin Shivappa; James R Hébert; Lisa E Paddock; Lorna Rodriguez-Rodriguez; Sara H Olson; Elisa V Bandera
Journal:  Nutrition       Date:  2017-09-23       Impact factor: 4.008

4.  The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study.

Authors:  Laurie Graffouillère; Mélanie Deschasaux; François Mariotti; Lola Neufcourt; Nitin Shivappa; James R Hébert; Michael D Wirth; Paule Latino-Martel; Serge Hercberg; Pilar Galan; Chantal Julia; Emmanuelle Kesse-Guyot; Mathilde Touvier
Journal:  J Nutr       Date:  2016-03-09       Impact factor: 4.798

5.  Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.

Authors:  Jennifer Ose; Helena Schock; Elizabeth M Poole; Matti Lehtinen; Kala Visvanathan; Kathy Helzlsouer; Julie E Buring; I-Min Lee; Anne Tjønneland; Marie-Christine Boutron-Ruault; Antonia Trichopoulou; Amalia Mattiello; N Charlotte Onland-Moret; Elisabete Weiderpass; María-José Sánchez; Annika Idahl; Ruth C Travis; Sabina Rinaldi; Melissa A Merritt; Nicolas Wentzensen; Shelley S Tworoger; Rudolf Kaaks; Renée T Fortner
Journal:  Cancer Causes Control       Date:  2017-02-16       Impact factor: 2.506

Review 6.  Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.

Authors:  Jennifer A Doherty; Allan Jensen; Linda E Kelemen; Celeste L Pearce; Elizabeth Poole; Joellen M Schildkraut; Kathryn L Terry; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

7.  Dietary inflammatory index and ovarian cancer risk in a large Italian case-control study.

Authors:  Nitin Shivappa; James R Hébert; Valentina Rosato; Marta Rossi; Maurizio Montella; Diego Serraino; Carlo La Vecchia
Journal:  Cancer Causes Control       Date:  2016-06-04       Impact factor: 2.506

8.  Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Authors:  Britton Trabert; Elizabeth M Poole; Emily White; Kala Visvanathan; Hans-Olov Adami; Garnet L Anderson; Theodore M Brasky; Louise A Brinton; Renee T Fortner; Mia Gaudet; Patricia Hartge; Judith Hoffman-Bolton; Michael Jones; James V Lacey; Susanna C Larsson; Gerardo G Mackenzie; Leo J Schouten; Dale P Sandler; Katie O'Brien; Alpa V Patel; Ulrike Peters; Anna Prizment; Kim Robien; V Wendy Setiawan; Anthony Swerdlow; Piet A van den Brandt; Elisabete Weiderpass; Lynne R Wilkens; Alicja Wolk; Nicolas Wentzensen; Shelley S Tworoger
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

Review 9.  A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus.

Authors:  Purab Pal; Kara Nicole Starkweather; Karen Held Hales; Dale Buchanan Hales
Journal:  Comp Med       Date:  2021-07-29       Impact factor: 0.982

10.  Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.

Authors:  Lauren C Peres; Mary K Townsend; Brenda M Birmann; Jose R Conejo-Garcia; Yongjoo Kim; Laura D Kubzansky; Larry I Magpantay; Otoniel Martinez-Maza; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-02-09       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.